US Patent Issued to Mitenyi Biotec on March 17 for "Engineered immune effector cells for cancer immunotherapy that are resistant to fratricide by virtue of having genetically modified surface antigens" (German Inventors)

ALEXANDRIA, Va., March 17 -- United States Patent no. 12,576,148, issued on March 17, was assigned to Mitenyi Biotec B.V. & Co. Kg (Bergisch Gladbach, Germany).

"Engineered immune effector cells for cancer immunotherapy that are resistant to fratricide by virtue of having genetically modified surface antigens" was invented by Michael Lutteropp (Bergisch Gladbach, Germany), Anne Richter (Bergisch Gladbach, Germany), Andrew Kaiser (Bergisch Gladbach, Germany), Mario Assenmacher (Bergisch Gladbach, Germany) and Stefan Miltenyi (Bergisch Gladbach, Germany).

According to the abstract* released by the U.S. Patent & Trademark Office: "This disclosure provides a system for preventing or reducing side effects in a patent undergoing immunotherapy t...